Chronic Insomnia: Clinical Trials

6 trials for Chronic Insomnia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed. 6 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 46Completed 6

Follow Chronic Insomnia: new trials by email Literature Review of Chronic Insomnia trials Research Report on Chronic Insomnia

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
CBT-I or Zolpidem/Trazodone for Insomnia
Zolpidem, Internet Cognitive Behavioral Therapy for Insomnia (CBT-I), Trazodone - Chronic Insomnia
Phase 4CompletedCalifornia Pacific Medical Center Research Institute1552022-02-252025-02-24
The Study of Combination Use of Melatonin Receptor Agonist for Dose Reduction or Interruptions of Benzodiazepine (BZD) and Non-BZD Hypnotics on Chronic Insomnia
Ramelteon 8mg, Placebo - Chronic Insomnia
Phase 4CompletedTranslational Research Center for Medical Innovation, Kobe, Hyogo, Japan172018-02-062024-11-20
Safety and Efficacy of Chronic Hypnotic Use 2
placebo, Zolpidem CR, Eszopiclone - Chronic Insomnia
Phase 4CompletedHenry Ford Health System412015-08-052024-03-29
Cognitive-Behavior Therapy for Insomnia
Cognitive-Behavior Therapy, Behavior Therapy, Cognitive Therapy - Chronic Insomnia
Phase 4CompletedLaval University1862008-04-012013-07-02
Facilitation of Zolpidem (≥10 mg) Discontinuation Through Use of Ramelteon in Subjects With Chronic Insomnia
Ramelteon and zolpidem, Placebo and zolpidem - Chronic Insomnia
Phase 4CompletedTakeda1352007-04-012010-07-20
Subjective Efficacy of Ramelteon on Sleep in Adults With Chronic Insomnia.
Ramelteon, Placebo - Chronic Insomnia
Phase 4CompletedTakeda5522006-10-012016-06-28

Narrower conditions

Sleep Initiation and Maintenance Disorders (6)  ·  Parasomnias (1)  ·  Sleep Wake Disorders (1)

Broader conditions

Dyssomnias (6)  ·  Mental Disorders (6)  ·  Nervous System Diseases (6)  ·  Sleep Disorders, Intrinsic (6)  ·  Sleep Wake Disorders (5)  ·  Neurologic Manifestations (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Signs and Symptoms (1)

Interventions

ramelteon (3)  ·  Zolpidem (2)  ·  Behavior Therapy (1)  ·  Cognitive Behavioral Therapy (1)  ·  Eszopiclone (1)  ·  Trazodone (1)

Sponsors

Takeda (2)  ·  California Pacific Medical Center Research Institute (1)  ·  Henry Ford Health System (1)  ·  Laval University (1)  ·  Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan (1)

Countries

United States (5)  ·  Canada (1)  ·  Japan (1)

Top investigators

Charles M. Morin, PhD (1)  ·  Daniel J. Buysse, MD (1)  ·  Katie L. Stone, PhD (1)  ·  Timothy A Roehrs, PhD (1)  ·  Yuichi Inoue, MD, Ph.D. (1)

Results publications

PMID 26763501, PMID 26963600, PMID 29265834, PMID 36821333